DUBLIN, Oct. 29, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback